Strattera Titration: What to Track in Your First Weeks

Two weeks into Strattera and still waiting to "feel" something is normal, but nobody tells you that in the fifteen-minute appointment where you're handed the prescription. Every ADHD forum post you've read is about stimulants — instant focus, an afternoon crash, appetite loss by lunch. Strattera doesn't work that way, and if you're tracking it like a stimulant, you'll misread your own data and possibly quit before it's had a chance to work.

Why Strattera Titration Looks Nothing Like Stimulant Titration

Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor, not a stimulant. It builds up in your system over four to six weeks before you see the full effect, similar to an antidepressant. There's no same-day focus bump to notice, no afternoon crash to log, no "is this working today" signal you can check by 3pm.

That means the biggest risk with a strattera titration tracker isn't logging the wrong side effects — it's giving up on logging entirely because nothing seems to be happening. People expect Adderall-style feedback and, when it doesn't arrive in week one, they assume the medication isn't working and stop paying attention right when the data matters most.

The other difference: dose increases on Strattera typically happen every few weeks, not every few days. Your prescriber is titrating slowly toward a target dose based on your weight and response, not fine-tuning a same-day effect. Your log needs to capture trends across weeks, not swings across hours.

What to Log During Weeks One Through Six

Since you won't feel a dramatic shift day to day, focus on the signals that build a trend line your prescriber can actually use:

Physical side effects, daily — Strattera's early side effects are mostly physical rather than cognitive: nausea, dry mouth, fatigue, and in some people, a mild increase in heart rate or blood pressure. These typically front-load in the first two weeks and fade. Log them daily even if they feel minor — a pattern of "nausea most mornings, resolving by week three" is exactly the kind of data your prescriber wants to see before deciding on the next dose increase.

Sleep and appetite, weekly average — Unlike stimulants, Strattera doesn't typically suppress appetite sharply, but some people notice changes in sleep quality during the first few weeks. Rather than logging every night, note a rough weekly pattern: better, worse, or unchanged.

Focus and mood, twice weekly — Because the effect builds slowly, daily focus scores tend to be noisy and unhelpful early on. Rate focus and mood twice a week instead, at a consistent time. By week four or five, you should start to see the numbers drift upward if the dose is working. If they're still flat at week six, that's useful information for your prescriber, not a failure on your part.

Anything that feels like it's improving, in your own words — Strattera's benefits tend to show up subtly — less mental noise, an easier time starting tasks, fewer forgotten commitments — rather than as a dramatic shift. These are easy to dismiss as coincidence. Write them down as they happen so you have specific examples instead of a vague "I think it's a little better."

Reading Your Data When Nothing Feels Different

The hardest part of a non-stimulant titration is trusting a log when your day-to-day experience feels unchanged. This is exactly when the log matters most, because your memory of week one will be gone by week six.

When you review your data before a follow-up, look for direction, not magnitude. Are physical side effects trending down? Are focus scores flat, slightly up, or still volatile? Is there a specific week where something shifted, even subtly? These trends are often invisible in the moment and only show up when you look at five or six weeks side by side.

If nothing has moved by week six or seven, that's a real, useful data point — it tells your prescriber the current dose likely isn't sufficient, and a change may be warranted. Without a log, that same conversation becomes "I don't think it's doing anything," which is much harder for a prescriber to act on.

Bringing a Non-Stimulant Log to Your Appointment

Your prescriber needs something different from you than they'd need from a stimulant patient. Instead of "here's what happened yesterday," they need "here's the trend over six weeks." Structure your summary around:

- Physical side effects by week (front-loaded and resolving, or persistent)
- Focus and mood trend across the full titration period, not single days
- Specific, dated examples of improvement or lack of it, in your own words
- Any side effect that hasn't resolved after four weeks — worth flagging explicitly

A clean multi-week view is worth more here than a detailed daily log, because the whole point of Strattera titration is that individual days don't tell you much.

The Calibrate app supports this kind of tracking directly — daily entries with side-effect tags and focus/energy scores, organized across your full titration window with phase-aware context, and a weekly PDF summary generated automatically so your prescriber sees the trend, not just isolated days. It's built for exactly this slow-burn titration pattern, where the value is in the arc, not any single entry.

If you're a few weeks into Strattera and still waiting for it to "kick in," keep logging. The absence of a dramatic effect isn't a sign it's failing — it's the expected shape of a non-stimulant titration, and your data is what turns that waiting period into a decision your prescriber can act on.